contractor articles (458)
Active Articles:
A52800: Self-Administered Drug Exclusion List: (SAD List)A54398: Response to Comments: Non-Invasive Cerebrovascular Studies
A54399: Response to Comments: Non-Invasive Peripheral Arterial Vascular Studies
A54400: Response to Comments: Non-Invasive Peripheral Venous Vascular and Hemodialysis Access Studies
A54402: Response to Comments: Non-Invasive Abdominal/Visceral Vascular Studies
A54562: Response to Comments: LCD 35998 Non-Coronary Vascular Stents
A54694: Response to Comments: Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back pain L36000
A54841: Response to Comments: Allergy Immunotherapy (L36408)
A54842: Response to Comments: Allergy Testing (L36402)
A54920: Response to Comments: Genetic Testing for Hypercoagulability /Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) L36400 (A54920)
A54923: Billing and Coding: Bariatric Surgery for Treatment of Co-Morbidities Conditions Related to Morbid Obesity
A54953: Independent Diagnostic Testing Facilities- physician supervision and technician requirements
A54958: Billing and Coding: Single Chamber and Dual Chamber Permanent Cardiac Pacemaker
A55003: Response to Comments: MolDX: Biomarkers in Cardiovascular Risk Assessment (L36523)
A55136: Billing and Coding: Lab: Immunohistochemistry (IHC) Indications for Breast Pathology
A55146: Billing and Coding: MolDX: BluePrint® Test
A55147: Billing and Coding: MolDX: bioTheranostics Cancer TYPE ID® Update
A55161: Billing and Coding: MolDX: FDA-Approved BRAF Tests
A55162: Billing and Coding: MolDX: FDA-Approved KRAS Tests
A55169: Billing and Coding: MolDX: HTTLPR Gene Testing
A55175: Billing and Coding: MolDX: MammaPrint®
A55193: Billing and Coding: MolDX: FDA-Approved EGFR Tests
A55197: Billing and Coding: MolDX: Targeted and Comprehensive Genomic Profile Testing in Cancer
A55200: Billing and Coding: MolDX: PIK3CA Gene Tests
A55206: Billing and Coding: MolDX: SEPT9 Gene Test
A55210: Billing and Coding: MolDX: SULT4A1 Genetic Testing
A55224: Billing and Coding: MolDX: Germline testing for use of PARP inhibitors
A55230: Billing and Coding: MolDX: Oncotype DX® Breast Cancer Assay
A55231: Billing and Coding: MolDX: Oncotype DX® Colon Cancer Assay Update
A55233: Billing and Coding: MolDx: BCR-ABL
A55235: Billing and Coding: MolDX: Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy (ARVD/C) Testing
A55381: Response to Comments: Polysomnography and Other Sleep Studies (L36839)
A55391: Response to Comments: MolDX: Molecular Diagnostic Tests (MDT) (L36807)
A55397: Response to Comments: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease (L36815)
A55400: Response to Comments: MolDX: NRAS Genetic Testing (L36797)
A55401: Response to Comments: MolDX: Breast Cancer Assay: Prosigna (L36811).
A55404: Response to Comments: Special Histochemical Stains and Immunohistochemical Stains (L36805)
A55533: Response to Comments: Visual Electrophysiology Testing (L37015)
A55535: Response to Comments: MolDX: MGMT Promoter Methylation Analysis (DL37001).
A55536: Response to Comments: MolDX: HLA-DQB1*06:02 Testing for Narcolepsy (DL37003).
A55540: Response to Comments: MolDX-CDD: ConfirmMDx Epigenetic Molecular Assay (DL37005).
A55543: Response to Comments: MolDX-CDD: ProMark Risk Score (DL37011).
A55621: Billing and Coding: MolDX: Short Tandem Repeat (STR) Markers and Chimerism (CPT® codes 81265-81268)
A55639: Billing and Coding: Chemotherapy Agents for Non-Oncologic Conditions
A55641: Response to Comments: Chemotherapy Drugs and their Adjuncts (L37205)
A55643: Response to Comments: MolDX: Decision Dx-UM (Uveal Melanoma) (DL37210).
A55644: Response to Comments: MolDX: Xpresys Lung (DL37216).
A55646: Response to Comments: MolDX: Percepta© Bronchial Genomic Classifier (DL37195).
A55648: Response to Comments: MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™) (DL37199).
A55738: Billing and Coding: MolDX: Abbott RealTime IDH1 and IDH2 testing for Acute Myeloid Leukemia (AML)
A55879: Response to Comments: MolDX: Prometheus IBD sgi Diagnostic Policy (L37539)
A55909: Billing and Coding: Wound Care
A55910: Response to Comments: Wound Care (DL37228)
A55951: Billing and Coding: Endometrial Hyperplasia Treatment with Intrauterine Device (Hormone-Eluting)
A56021: Response to Comments: MolDX: EndoPredict® Breast Cancer Gene Expression Test (DL37663).
A56157: Billing and Coding: Intraarticular Knee Injections of Hyaluronan
A56169: Response to Comments: MolDX: Multiplex Nucleic Acid Amplified Tests for Respiratory Viral Panels (DL37764)
A56232: Billing and Coding: Foot Care
A56233: Response to Comments: MolDX: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification Tests (NAATs) (DL37766)
A56273: Billing and Coding: Chiropractic Services
A56333: Billing and Coding: MolDX: Inivata™, InVisionFirst®, Liquid Biopsy for Patients with Lung Cancer
A56335: Billing and Coding: MolDX: Breast Cancer Index® (BCI) Gene Expression Test
A56336: Response to Comments: MolDX: Inivata, InVisionFirst, Liquid Biopsy for Patients with Lung Cancer (BCI) Gene Expression Test (DL37921)
A56338: Response to Comments: MolDX: Breast Cancer IndexTM (BCI) Gene Expression Test (DL37913)
A56394: Billing and Coding: Colonoscopy and Sigmoidoscopy-Diagnostic
A56395: Billing and Coding: Endoscopic Treatment of GERD
A56399: Response to Comments: MolDX: MDS FISH (DL37772)
A56402: Response to Comments: MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test (DL37919)
A56635: Response to Comments: MolDX: DecisionDX-Melanoma (L38018)
A56636: Billing and Coding: MolDX: Melanoma Risk Stratification Molecular Testing
A56795: Billing and Coding: Erythropoiesis Stimulating Agents (ESAs)
A56900: Billing and Coding: Immunizations
A56902: Billing and Coding: Category III Codes
A56903: Billing and Coding: Polysomnography and Other Sleep Studies
A56905: Billing and Coding: Surgical Treatment of Obstructive Sleep Apnea (OSA)
A56907: Billing and Coding: Bisphosphonate Drug Therapy
A56908: Billing and Coding: Blepharoplasty, Blepharoptosis and Brow Lift
A56910: Billing and Coding: Corneal Hysteresis
A56914: Billing and Coding: Treatment of Varicose Veins of the Lower Extremities
A56915: Billing and Coding: Urine Drug Testing
A56916: Billing and Coding: Scanning Computerized Ophthalmic Diagnostic Imaging (SCODI)
A56917: Response to Comments: Corneal Hysteresis L38211
A57100: Billing and Coding: MolDX: Repeat Germline Testing
A57106: Billing and Coding: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease
A57110: Billing and Coding: MolDX: Blood Product Molecular Antigen Typing
A57472: Billing and Coding: Allergy Immunotherapy
A57473: Billing and Coding: Allergy Testing
A57474: Billing and Coding: Botulinum Toxin Type A & Type B
A57476: Billing and Coding: Electrocardiographic (EKG or ECG) Monitoring (Holter or Real-Time Monitoring)
A57477: Billing and Coding: Mohs Micrographic Surgery
A57478: Billing and Coding: Nerve Conduction Studies and Electromyography
A57479: Billing and Coding: Percutaneous Coronary Interventions
A57480: Billing and Coding: Psychiatry and Psychology Services
A57481: Billing and Coding: Psychological and Neuropsychological Testing
A57482: Billing and Coding: Removal of Benign Skin Lesions
A57483: Billing and Coding: Visual Fields
A57484: Billing and Coding: Vitamin D Assay Testing
A57551: Billing and Coding: Autonomic Function Testing
A57552: Billing and Coding: Coronary Computed Tomography Angiography (CCTA)
A57558: Billing and Coding: BDX-XL2
A57559: Billing and Coding: MolDX: Biomarkers in Cardiovascular Risk Assessment
A57560: Billing and Coding: MolDX: Breast Cancer Assay: Prosigna®
A57567: Billing and Coding: MolDX: EndoPredict® Breast Cancer Gene Expression Test
A57568: Billing and Coding: MolDX: Envisia™, Veracyte™, Idiopathic Pulmonary Fibrosis Diagnostic Test
A57570: Billing and Coding: MolDX: Genetic Testing for BCR-ABL Negative Myeloproliferative Disease
A57571: Billing and Coding: MolDX: Genetic Testing for Hypercoagulability/Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR)
A57575: Billing and Coding: MolDX: HLA-DQB1*06:02 Testing for Narcolepsy
A57576: Billing and Coding: MDS FISH
A57577: Billing and Coding: MolDX: MGMT Promoter Methylation Analysis
A57581: Billing and Coding: MolDX: NRAS Genetic Testing
A57583: Billing and Coding: MolDX: Oncotype DX® Breast Cancer for DCIS (Genomic Health™)
A57587: Billing and Coding: ProMark® Risk Score
A57588: Billing and Coding: MolDX: Prometheus® IBD sgi Diagnostic® Policy
A57589: Billing and Coding: Nerve Blocks for Peripheral Neuropathy
A57590: Billing and Coding: Non-Coronary Vascular Stents
A57591: Billing and Coding: Non-Invasive Abdominal / Visceral Vascular Studies
A57592: Billing and Coding: Non-Invasive Cerebrovascular Studies
A57593: Billing and Coding: Non-Invasive Peripheral Arterial Vascular Studies
A57594: Billing and Coding: Non-Invasive Peripheral Venous Vascular and Hemodialysis Access Studies
A57595: Billing and Coding: Pelvic Floor Dysfunction: Anorectal Manometry and EMG
A57596: Billing and Coding: Percutaneous minimally invasive fusion/stabilization of the sacroiliac joint for the treatment of back pain
A57597: Billing and Coding: Somatosensory Testing
A57598: Billing and Coding: Transcranial Magnetic Stimulation (TMS)
A57599: Billing and Coding: Visual Electrophysiology Testing
A57604: Billing and Coding: Intraoperative Neurophysiological Testing
A57630: Billing and Coding: Percutaneous Vertebral Augmentation (PVA) for Vertebral Compression Fracture (VCF)
A57631: Response to Comments: Percutaneous Vertebral Augmentation (PVA) for Osteoporotic Vertebral Compression Fracture (VCF) L38213
A57733: Billing and Coding: Lab: Special Histochemical Stains and Immunohistochemical Stains
A57772: Billing and Coding: MolDX: Molecular Diagnostic Tests (MDT)
A57844: Response to Comments: Erythropoiesis Stimulating Agents (ESAs) (L34633)
A57846: Response to Comments: DL37228 Wound Care
A57851: Billing and Coding: MolDX: HLA Testing for Transplant Histocompatibility
A57858: Billing and Coding: MolDX: Next-Generation Sequencing for Solid Tumors
A57861: Response to Comments: Next-Generation Sequencing for Solid Tumor (DL38158)
A57878: Billing and Coding: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies
A57879: Response to Comments: MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies (DL38176)
A57880: Billing and Coding: MolDX: Testing of Multiple Genes
A57935: Response to Comments: MolDX: Plasma-Based Genomic Profiling in Solid Tumors (L38168)
A57936: Billing and Coding: MolDX: Plasma-Based Genomic Profiling in Solid Tumors
A57944: Billing and Coding: Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnea
A57979: Response to Comments: MolDX: Pigmented Lesion Assay
A57983: Billing and Coding: MolDX: Pigmented Lesion Assay
A58117: Response to Comments: MolDX: Predictive Classifiers for Early Stage Non-small Cell Lung Cancer (L38443)
A58118: Response to Comments: MolDX: Repeat Germline Testing (L38429)
A58119: Response to Comments: Hypoglossal Nerve Stimulation for Treatment of Obstructive Sleep Apnea (DL38528).
A58198: Response to Comments: MolDX Pharmacogenomics Testing (DL38435)
A58205: Billing and Coding: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
A58207: Billing and Coding: MolDX: Molecular Testing for Solid Organ Allograft Rejection
A58209: Billing and Coding: Transurethral Waterjet Ablation of the Prostate
A58211: Billing and Coding: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
A58213: Billing and Coding: Implantable Continuous Glucose Monitors (I-CGM)
A58395: Billing and Coding: MolDX: Pharmacogenomics Testing
A58396: Response to Comments: Implantable Continuous Glucose Monitors (I-CGM) DL38686
A58416: Response to Comments: MolDX: Minimal Residual Disease Testing for Colorectal Cancer
A58431: Response to Comments: MolDX: Blood Product Molecular Antigen Typing (L38441)
A58450: Response to Comments: MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease (DL38433)
A58468: Billing and Coding: MolDX: Minimal Residual Disease Testing for Solid Tumor Cancers
A58471: Billing and Coding: Colon Capsule Endoscopy (CCE)
A58477: Billing and Coding: Facet Joint Interventions for Pain Management
A58514: Response to Comments: MolDX: DecisionDX-Melanoma
A58539: Response to Comments: Transurethral Waterjet Ablation of the Prostate (L38682)
A58568: Response to Comments: Endoscopic Treatment of GERD (DL34659)
A58624: Response to Comments: Colon Capsule Endoscopy (CCE) (DL38837)
A58671: Response to Comments: Non-Invasive Fractional Flow Reserve (FFR) for Stable Ischemic Heart Disease (L38839)
A58672: Response to Comments: Facet Joint Interventions for Pain Management (DL38841)
A58676: Response to Comments: MolDX: Breast Cancer Index® (BCI) Gene Expression Test
A58689: MolDX: Algorithm definition as a component of a laboratory test
A58703: Response to Comments: MolDX: Molecular Testing for Solid Organ Allograft Rejection
A58752: Response to Comments: MolDX: EndoPredict® Breast Cancer Gene Expression Test
A58756: Billing and Coding: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer
A58759: Billing and Coding: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
A58774: Billing and Coding: Cosmetic and Reconstructive Surgery
A58777: Billing and Coding: Epidural Steroid Injections for Pain Management
A58791: Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer DL38684
A58792: Response to Comments: MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells
A58896: Response to Comments: Cosmetic and Reconstructive Surgery (DL39051)
A58907: Response to Comments: Botulinum Toxin Type A & Type B (DL34635)
A58919: Response to Comments: Epidural Steroid Injections for Pain Management (DL39054)
A58930: Response to Comments: MolDX: Minimal Residual Disease Testing for Cancer (DL38835)
A59004: Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers
A59020: Response to Comments: MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing
A59090: Response to Comments: Category III Codes-(DL35490)
A59116: Response to Comments: MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer (DL39040)
A59117: Response to Comments: MolDX: Melanoma Risk Stratification Molecular Testing
A59118: Response to Comments: MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer
A59121: Billing and Coding: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
A59161: Response to Comments: Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease (DL38839)
A59237: Response to Comments: Transcranial Magnetic Stimulation (TMS) (DL34641)
A59257: Billing and Coding: Sacroiliac Joint Injections and Procedures
A59259: Billing and Coding: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin
A59306: Response to Comments: Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin (DL39477)
A59329: Response to Comments: Sacroiliac Joint Injections and Procedures (DL39475)
A59360: Response to Comments: MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia
A59369: Response to Comments: Intraarticular Knee Injections of Hyaluronan
A59429: Billing and Coding: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
A59434: Billing and Coding: Amniotic and Placental-Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound
A59455: Response to Comments: MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma
A59456: Response to Comments: MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer
A59534: Response to Comments: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
A59535: Response to Comments: Transurethral Waterjet Ablation of the Prostate DL38682
A59536: Billing and Coding: MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
A59549: Billing and Coding: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers
A59551: Billing and Coding: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
A59560: Billing and Coding: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
A59562: Response to Comments: Urine Drug Testing (DL34645)
A59563: Response to Comments: Amniotic and Placental Derived Product Injections and/or Applications for Musculoskeletal Indications, Non-Wound – DL39624
A59621: Response to Comments: Cataract Extraction
A59622: Response to Comments: Bisphosphonate Drug Therapy (DL34648)
A59649: Billing and Coding: MolDX: Proteomics Testing
A59664: Billing and Coding: Cervical Fusion
A59675: Response to Comments: Trigger Point Injections (TPI) (DL39713)
A59700: MolDX: Defining panel services in MolDX
A59703: Response to Comments: Implantable Continuous Glucose Monitors (I-CGM)
A59798: MolDX: Clarification of Order Requirements for Laboratory and Molecular Diagnostic services
A59799: Response to Comments: Face Joint Interventions for Pain Management (DL38841)
A59800: Response to Comments: Cervical Fusion (DL39788)
A59801: Response to Comments: Lab: Special Histochemical Stains and Immunohistochemical Stains
A59805: Billing and Coding: Cataract Surgery
A59811: Billing and Coding: Total Joint Arthroplasty
A59813: Billing and Coding: Artificial Intelligence Enabled CT Based Quantitative Coronary Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)
A59825: Response to Comments: MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules
A59844: Response to Comments: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma
A59875: Response to Comments: MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers L39709
A59876: Response to Comments: MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy
A59902: Response to Comments: Total Joint Arthroplasty (DL39911)
A59903: Response to Comments: Cosmetic and Reconstructive Surgery DL39051
A59904: Response to Comments: Cataract Surgery (DL39905)
A59934: Response to Comments: Micro-Invasive Glaucoma Surgery (MIGS) (DL39907)
A59937: Response to Comments: Artificial Intelligence Enabled CT Based Quantitative Topography (AI-QCT)/Coronary Plaque Analysis (AI-CPA)
Retired Articles:
A47448: Usually Self-Administered Drugs 2008A49374: Self-Administered Drug Exclusion List (SAD List)
A54176: Billing and Coding: Drug Administration
A55052: Billing and Coding: Radiopharmaceutical Agents
A55135: Billing and Coding: MolDX: Genetic Testing for Lynch Syndrome
A55137: Billing and Coding: MolDX 4q25-AF Risk Genotype Testing
A55138: Billing and Coding: MolDX: 9p21 Genotype Test
A55140: Billing and Coding: MolDX: AlloMap
A55141: Billing and Coding: MolDX: ApoE Genotype
A55145: Billing and Coding: MolDX: BCKDHB Gene Test
A55159: Billing and Coding: MolDX: ENG and ACVRL1 Gene Tests
A55164: Billing and Coding: MolDX: GBA Genetic Testing
A55165: Billing and Coding: MolDX: HAX1 Gene Sequencing
A55166: Billing and Coding: MolDX: HBB Gene Tests
A55171: Billing and Coding: MolDX: KIF6 Genotype
A55172: Billing and Coding: MolDX: know error®
A55173: Billing and Coding: MolDX: LPA-Aspirin Genotype
A55174: Billing and Coding: MolDX: LPA-Intron 25 Genotype
A55190: Billing and Coding: MolDX: Mitochondrial Nuclear Gene Tests
A55191: Billing and Coding: MolDX: MMACHC Test
A55196: MolDX: Next Generation Sequencing (NGS) and Tier 1 and Tier 2 Coding and Billing Guidelines
A55198: Billing and Coding: MolDX: NSD1 Gene Tests
A55199: Billing and Coding: MolDX: PAX6 Gene Sequencing
A55203: Billing and Coding: MolDX: PTCH1 Gene Testing
A55205: Billing and Coding: MolDX: RPS19 Gene Tests
A55208: Billing and Coding: MolDX: SMPD1 Genetic Testing
A55211: Billing and Coding: MolDX: TERC Gene Tests
A55232: Billing and Coding: MolDX: VEGFR2 Tests
A55234: Billing and Coding: MolDX: CYP2B6 Test
A55245: Billing and Coding: MolDX: OncoCee™
A55248: MolDX: Approved Gene Testing
A55353: Billing and Coding for Rezum® Procedure
A55622: Billing and Coding: MolDX: CDH1 Genetic Testing
A55640: Not Otherwise Classified Chemotherapy Agents (NOC) Billing and Coding Guidelines
A55846: Billing and Coding: MolDX: ThermoFisher Oncomine™ Dx Target Test For Non-Small Cell Lung Cancer
A56274: Billing and Coding: Human Granulocyte/Macrophage Colony Stimulating Factors
A56277: Billing and Coding: MolDX: clonoSEQ® Assay for Assessment of Minimal Residual Disease (MRD) in Patients with Specific Lymphoid Malignancies
A56332: Billing and Coding: Lab: Bladder/Urothelial Tumor Markers
A56334: Billing and Coding: MolDX: Genomic Health™ Oncotype DX® Prostate Cancer Assay
A56637: Billing and Coding: Foodborne Gastrointestinal Panels Identified by Multiplex Nucleic Acid Amplification Tests (NAATs)
A56901: Billing and Coding: MolDX: APC and MUTYH Gene Testing
A57561: Billing and Coding: MolDX: ConfirmMDx Epigenetic Molecular Assay
A57562: Billing and Coding: MolDX: CORUS® CAD ASSAY
A57565: Billing and Coding: MolDX: Decipher® Prostate Cancer Classifier Assay
A57578: Billing and Coding: MolDX: Molecular RBC Phenotyping
A57580: Billing and Coding: MolDX: myPath® Melanoma Assay
A57771: Billing and Coding: MolDX: BRCA1 and BRCA2 Genetic Testing
A58544: Billing and Coding: Complex Drug Administration Coding
A59431: Billing and Coding: Micro-Invasive Glaucoma Surgery (MIGS)